Among other targets, type-I interferon promotes the tumor suppressor TRIML2, which also elicits antiviral and antibacterial activities [55]; it participates in the correct development of macrophages and in the expression of nitric oxide and of the major histocompatibility complex II to present antigens [56]. This evidence concerns the gene TRIML2 and neoplasm.